‘We Are Not Against Quality’: MSME Drug Makers Seek 3-Year ‘Condition-Free’ Extension For Schedule-M Upgrade

Drugmakers are also irked by the wording of the undertaking they are mandated to sign for seeking a 12-month extension on applications of Schedule M

Leave a Reply

Your email address will not be published. Required fields are marked *